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FDC-PI is a murine myeloid cell line that requires interleukin 3 (IL3) for survival and proliferation. While the biological 
effects of IL3 have been well described, the biochemical mechanisms of IL3 actions have only recently been examined. 
We have investigated whether IL3 or PMA stimulates phosphorylation f proteins on tyrosine as well as on serine/threo- 
nine residues as previously described [(1986) Blood 68, 906-913; (1987) Biochem. J. 244, 683-691]. Here we report hat 
both IL3 and PMA stimulate the tyrosine phosphorylation f at least wo proteins: pp70 and pp50 in FDC-P1 cells. 
Interleukin 3; Phorbol ester; Tyrosine kinase; Phosphorylation 
1. INTRODUCTION 
IL3 is a member of the family of polypeptide 
colony-stimulating factors (CSFs) that collectively 
regulate the proliferation and differentiation f all 
of the myeloid blood cell lineages [4]. The recent 
molecular cloning of murine IL3 [5] together with 
the establishment of IL3-dependent cell lines [6] 
has allowed investigations into the biochemical 
mechanisms of IL3 actions. In previous reports we 
described the IL3-dependent translocation of PK- 
C as well as the serine/threonine phosphorylation 
of several proteins that were also phosphorylated 
in response to pharmacological activators of PK-C 
[I-3]. We found, however, that while both IL3 
and PMA or OAG stimulated the phosphorylation 
of certain proteins in common, some unique pro- 
teins were phosphorylated only in response to IL3. 
This indicated that while PK-C, or a PK-C-like 
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kinase, was probably involved in IL3 signal 
transduction, other kinase systems were also ac- 
tivated. These studies were interesting in view of 
findings that phorbol esters replace IL3 for the 
regulation of DNA synthesis, ATP regeneration 
and hexose transport in CSF-dependent cell lines 
[7]. 
A variety of oncogenes [8] as well as many 
growth factor receptors [9] possess protein tyrosine 
kinase activity. It has been postulated that tyrosine 
phosphorylation is involved in these growth factor 
signal transduction pathways and in the abroga- 
tion of serum dependence in cell lines transformed 
by viral oncogenes encoding tyrosine kinases. 
Moreover, IL3-dependent cell lines have been 
transformed by tyrosine kinase oncogenic proteins 
such as v-abl [10,11]. In nontransformed factor- 
dependent cell lines the importance of tyrosine 
phosphorylation to signal transduction and pro- 
liferation has been difficult to assess because 
phosphotyrosine typically accounts for less than 
1 °7o of the total phosphoamino acids present in 
cellular extracts. The availability of antiphospho- 
tyrosine antibodies [12], however, has greatly 
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simplified analysis of tyrosine phosphorylation 
and several recent reports have described stimula- 
tion of tyrosine kinase activity by IL3 [13,15]. 
Here we have used antiphosphotyrosine antibodies 
coupled to Sepharose and two-dimensional gel 
electrophoresis to purify and characterize proteins 
phosphorylated on tyrosine residues following 
either IL3 or PMA treatment of the myeloid, 
IL3-dependent cell line, FDC-P1. 
2. MATERIALS AND METHODS 
2.1. Cells 
FDC-P 1 cells were routinely grown in RPMI- 1640/10% fetal 
calf serum/l% glutamine and penicillin-streptomycin sup- 
plemented with 10% conditioned medium from the WEHI-3 
cell line. For labeling and ligand stimulation, FDC-P 1 cells were 
washed twice in phosphate-free RPMI-1640 and resuspended at 
2 × 106 cells/ml for 20 min at 37°C. The cells were then washed 
and resuspended in phosphate-free RPMI-1640 at 1.5 × 107/ml 
in a volume of 1 ml in Eppendorf tubes. 
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Fig.l. Two-dimensional NEPHGE analysis of antiphosphoty- 
rosine affinity-purified phosphoproteins from IL3-stimulated 
FDC-P1. The phosphate-labeled, growth-arrested cells were 
stimulated with IL3 for the indicated times and prepared for 
NEPHGE analysis as described in section 2. The locations of 
two phosphoproteins modulated by IL3 are indicated. The 
histogram shows the -fold increases in radioactivity 
incorporated into the proteins as determined using a two- 
dimensional laser densitometer (LKB Ultrascan XL) and LKB 
scanning software. 
2.2. Phosphate labeling and antiphosphotyrosine affinity 
adsorption 
[32p]Orthophosphate (Amersham, 8 mCi/ml) was neutral- 
ized to pH 7.2 with NaOH and 0.5 mCi (about 0.1 ml) was add- 
ed to each tube. Following 2-3 h equilibration at 37°C in a 
shaking water bath, 100 U/106 cells of recombinant E. coli- 
derived murine IL3 (Biogen) was added in a volume of 0.05 ml. 
Cells were resuspended, vortex-mixed for 3 s and replaced in 
the shaking water bath. At the indicated time points cells were 
rapidly pelleted (8000 rpm/10 s) in a microfuge and washed 
once with 1.0 ml cold PBS. 
Cell pellets were resuspended in 0.1 ml buffer A (20 mM 
Hepes, pH 7.2/0.207o SDS/0.15 M NaCl/1 mM EDTA) and 
boiled in a water bath for 10 min. Upon rapid cooling on ice, 
extracts were mixed with Triton X-100 to give 107o final concen- 
tration. After 30 rain on ice, the extracts were clarified by cen- 
trifugation at 10000 rpm for 10 min in a microfuge and 0.02 ml 
antiphosphotyrosine-coupled Sepharose was added. Affinity 
adsorption proceeded overnight, with rotation, at 4°C. The 
suspensions were centrifuged at 12000 rpm for 10 min and 
washed twice with 0.6 ml buffer A. Phosphotyrosyl proteins 
were specifically eluted from the affinity capture beads by the 
addition of 0.1 ml of 50 mM phosphotyrosine (Sigma), pH 7.2, 
in buffer A. The samples were rotated at 4°C for 1 h then cen- 
trifuged at 12000 rpm for 10 min. 
2.3. Two-dimensional NEPHGE analysis 
Samples (80/d) of the supernatants were removed and a ded 
to 50 mg urea, 30/zl IEF sample buffer [9.5 M urea, 2070 (w/v) 
Fig.2. Phosphoamino acid analysis of pp50 and pp70 after IL3 
stimulation. The areas on the 2D NEPHGE gels corresponding 
to pp50 and pp70 on the autoradiographs were sliced out, and 
the proteins eluted and hydrolyzed in 6N HCI. The 
hydrolysates were mixed with phosphoamino acid standard and 
subjected to high-voltage, single-dimension thin-layer 
electrophoresis. Positions of the standards were located with 
ninhydrin (dashed circles) and radioactive phosphoamino acids 
were located by autoradiography in the presence of intensifying 
screens. 
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NP40, pH 5-7 ampholines (1.6070), pH 3.5-10 ampholines 
(0.407o) 507o 2-mercaptoethanol] and l0 ~l of 10070 NP40. Stan- 
dard NEPHGE gels were lectrophoresed for 6 h at 500 V, then 
the tube gels were removed, and equilibrated for 30 min in con- 
centrated SDS sample buffer. Tube gels were attached and elec- 
trophoresed on 1007o SDS slab gels. Gels were supported on 
filter paper, dried (Biorad gel drier, Richmond, CA) and 
autoradiography performed (Kodak X-Omat or SB film) at 
room temperature. 
2.4. Phosphoamino acid analysis 
The locations of phosphorylated proteins identified by 
autoradiography were excised from the gels and placed in 
0.5 ml extraction buffer (50 mM NH4CO3, 0.1°70 SDS, 5°7o 
2-mercaptoethanol), boiled for 5 min and shaken for 24-36 h 
at 37°C. Extracted proteins were dried on a rotary evaporator 
(Savant) and washed once with 0.1 ml of 20070 trichloroacetic 
acid at 4°C and three times with ethanol/ether (3 :1). After air- 
drying the samples were hydrolyzed for 1.5 h at 110°C in 0.4 ml 
of 6 N HC1 and dried on the rotary evaporator. 
Single-dimension thin-layer electrophoresis was carried out at 
1500 V for 45 min using cellulose acetate thin-layer plates with 
pyridine/glacial acetic acid/water (10:100:1890) pH 3.5. 
Phosphoamino acids were identified using unlabeled standards 
located with ninhydrin and radioactive amino acids were iden- 
tified by autoradiography. 
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Fig.3. Two-dimensional NEPHGE analysis of antiphosphotyrosine affinity-purified phosphoproteins from PMA stimulatedFDC--Pl. 
The phosphate-labeled, growth-arrested cells were stimulated with PMA for the indicated times and prepared and analyzed as 
described. The histogram shows -fold increases in radioactivity incorporated into the indicated phosphoproteins. 
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3. RESULTS 
3.1. IL3 stimulated tyrosine phosphorylation 
Actively growing FDC-P 1 cells were washed and 
labeled as described in section 2. After a 2 h 
equilibration period with 32pi the ceils were treated 
with IL3 for various lengths of time. 
We examined the time course of protein 
phosphorylation i duced by IL3 by 2-dimensional 
nonequilibrating pH gradient gel electrophoresis 
(NEPHGE) as described. The technique used a low 
concentration of urea to examine selectively those 
proteins with a high solubility in urea. This en- 
abled a very high resolution of a few proteins to be 
obtained. After affinity purification and selective 
solubilization pp70 and pp50 were the most promi- 
nent proteins observed in 2D NEPHGE autoradio- 
graphs. In these experiments we found that these 
two proteins were rapidly phosphorylated in 
response to IL3 (fig.l). Within 1 min pp70, the 
most prominent phosphoprotein, u derwent a 
2-fold increase in phosphorylation and continued 
to reach 6-fold after 10 rain. During the same 
period, pp50 phosphorylation i creased 4.5-fold. 
Phosphoamino acid analysis (fig.2) confirmed that 
both of these proteins contained phosphotyrosine 
as well as phosphoserine. Since the ratios of phos- 
photyrosine to phosphoserine (40:60 for pp70, 
and 90:10 for pp50) did not change significantly 
with time (not shown), we concluded that IL3 
simultaneously stimulated phosphorylation by a 
tyrosine kinase and a serine kinase. 
3.2. Phorbol ester-stimulated tyrosine 
phosphorylation 
Two-dimensional analysis of these two 
phosphotyrosyl proteins affinity purified from ex- 
tracts of PMA-treated cells revealed (fig.3) a more 
rapid time course of phosphorylation. Increases in 
phosphorylation of both proteins were apparent 
within 1 min after PMA application, and the in- 
corporation in pp70 peaked by 5 min, followed by 
steadily decreasing so that by 60 min the level of 
pp70 phosphorylation was less than that found in- 
itially in the factor-starved cells. In contrast, 
phosphorylation of pp50 remained significantly 
elevated even at 60 min. 
Phosphoamino acid analysis of pp70 purified 
from PMA-treated cells (fig.4) revealed a ratio of 
phosphotyrosine to phosphoserine (45:55) similar 
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Fig.4. Phosphoamino acid analysis of pp70 after PMA 
stimulation. The areas on the 2D NEPHGE gels corresponding 
to pp70 on the autoradiographs were excised, and the proteins 
eluted and hydrolyzed in 6 N HC1. The hydrolysates were mix d 
with phosphoamino acid standard and subjected to high- 
voltage, single-dimension thin-layer electrophoresis. Positions 
of the standards were located with ninhydrin (dashed circles) 
and radioactive phosphoamino acids were located by 
autoradiography in the presence of intensifying screens. 
to that found in pp70 from extracts of 
IL3-stimulated cells (40:60). This uggests that the 
same, or similar, kinase(s) are involved in both 
cases. We were unable to perform phosphoamino 
acid analysis on pp50 purified from PMA-treated 
cells due to low recovery of the excised 
phosphoprotein. 
The two proteins examined in extracts from IL3- 
and PMA-treated ceils are identical, as shown by 
direct comparison of the two-dimensional gel 
autoradiographs (fig.5). 
0 .......... IL-3 PMA 
Fig.5. Comparison of PMA- and IL3-stimulated 
phosphorylation. Autoradiographs from control, 10 min IL3 
and PMA NEPHGE are shown. 
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4. DISCUSSION 
Reversible phosphorylation of proteins is 
recognized as the major mechanism of regulating 
the functions of proteins. It is important in such 
diverse cellular processes as intermediary metabo- 
lism, differentiation, mitosis and cytokinesis. 
Early work demonstrated that levels of phosphate 
incorporated into histones varied with the cell cycle 
[16,17] and that the phosphorylation state of non- 
histone DNA-binding proteins affected in vitro 
transcription rates [18]. The discoveries that cer- 
tain viral oncogene products [19] and growth fac- 
tor receptors [20,21] possessed tyrosine kinase 
activity provided further support for the idea that 
phosphorylation, and tyrosine phosphorylation i  
particular, were important to cellular prolifera- 
tion. Recent molecular studies have shown that the 
tyrosine kinase activities of a variety of growth fac- 
tor receptors and oncogene products are required 
for their biological effects [22-24]. 
Other kinase systems have also been implicated 
in growth control. The cyclic adenosine mono- 
phosphate-dependent protein kinase (PK-A) has 
often been associated with negative growth control 
and even with reversal of transformation [25,26], 
while the potent effects of the tumor-promoting 
phorbol esters have been attributed to the activities 
of the major intracellular phorbol ester-binding 
protein, PK-C [27]. These studies have provided 
the conceptual framework to interpret results im- 
plicating kinase activity in the biochemical 
mechanisms of actions of the colony-stimulating 
factors. Each of the hemopoietic growth factors 
have now been molecularly cloned, but to date 
only the receptor for colony-stimulating factor 1 
(CSF-1) has been characterized by sequence homo- 
logy and enzyme activity to be a tyrosine kinase, 
homologous to the v-fins oncogene product [28]. 
Previously we reported that IL3 as well as G- 
CSF stimulated the serine/threonine phosphoryla- 
tion of a 68 kDa protein in a variety of CSF- 
dependent cell lines. This protein was also similarly 
phosphorylated in response to pharmacological ac- 
tivators of PK-C. We postulated that PK-C, or an 
analogous kinase system, was involved in the 
biological action of IL3 and G-CSF and that p68 
phosphorylation might represent a point of con- 
vergence for several signal transduction pathways 
leading to proliferation. Recently, Whetton et al. 
[29] have shown that IL3 may activate a PK-C-like 
system in the absence of detectable phosphoino- 
sitol 4,5-bisphosphate hydrolysis, suggesting an 
atypical mechanism activating PK-C. 
Abrogation of the IL3 dependence of murine 
IL3-dependent cell lines has been achieved by in- 
fection with the Abelson murine l ukemia virus, a 
virus that encodes the v-abl tyrosine kinase on- 
cogene product [10,I1]. In addition Pierce et al. 
[30] have introduced the gene encoding the epider- 
mal growth factor receptor into IL3-dependent 
cells and established EGF-dependent cell growth. 
Their work shows that tyrosine kinase activity can 
substitute for IL3, which suggests that the 
mechanism of IL3 biological activity involves 
amplification of tyrosine phosphorylation of a 
select group of proteins. In support of this idea, 
Koyasu et al. [13] reported that IL3 induced the 
tyrosine phosphorylation of a 150 kDa membrane 
glycoprotein and suggested that the 150 kDa pro- 
tein might be closely associated with the IL3 recep- 
tor. We have shown by two-dimensional nalysis 
of antiphosphotyrosine affinity-purified proteins 
that IL3 and PMA stimulate phosphorylation on 
both tyrosine and serine residues of two proteins 
with similar kinetics. Since we found that the ratios 
of phosphotyrosine to phosphoserine in pp50 or 
pp70 did not change after IL3 application we con- 
clude that both a tyrosine and a serine/threonine 
kinase analogous to PK-C must be co-activated 
following IL3 treatment. We further suggest hat 
PMA is also able to activate both types of protein 
kinase activities as demonstrated by increases in 
serine and tyrosine phosphorylation. This result is 
in agreement with previous observations of PMA 
stimulation of tyrosine kinase activity [31,32]. A 
corollary to this is that the tumor-promoting 
abilities of phorbol esters may involve the activa- 
tion of tyrosine kinase systems by PK-C. We 
believe our findings are consistent with previous 
reports of interkinase regulation [33,34] and 
strongly implicate such kinase 'cross-talk' in the 
IL3 signal transduction pathway. 
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